Carpachromene Ameliorates Insulin Resistance in HepG2 Cells via Modulating IR/IRS1/PI3k/Akt/GSK3/FoxO1 Pathway

Rania Alaaeldin1, Iman A M Abdel-Rahman2, Heba Ali Hassan3

  • 1Department of Biochemistry, Faculty of Pharmacy, Deraya University, Minia 61111, Egypt.

Insights

Carpachromene, a natural compound, enhances glucose metabolism and insulin signaling in liver cells. This study reveals its potential antidiabetic activity by improving insulin receptor function and key metabolic pathways.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Insulin resistance is a key factor in type 2 diabetes and cardiovascular diseases.
  • Carpachromene, a natural compound, is known to inhibit the alpha-glucosidase enzyme.
  • Understanding carpachromene's effects on glucose metabolism and insulin signaling is crucial for developing new antidiabetic therapies.

Purpose of the Study:

  • To investigate the effects of carpachromene on glucose consumption, metabolism, and insulin signaling.
  • To establish and utilize a HepG2 cell model of insulin resistance (HepG2/IRM).
  • To elucidate the molecular mechanisms underlying carpachromene's potential antidiabetic activity.

Main Methods:

  • Established a HepG2 insulin resistant cell model (HepG2/IRM).
  • Assessed cell viability, glucose concentration, and glycogen content following carpachromene treatment.
  • Utilized Western blot analysis to examine key proteins in the insulin signaling pathway (IR, IRS1, PI3K, Akt, GSK3, FoxO1) and measured PEPCK and HK enzyme activities.

Main Results:

  • Carpachromene treatment (6.3-20 µg/mL) showed over 90% cell viability in HepG2/IRM cells.
  • Carpachromene significantly decreased glucose concentration and increased glycogen content in a dose- and time-dependent manner.
  • Carpachromene enhanced insulin receptor signaling by increasing phosphorylated/total ratios of key proteins (IR, IRS1, PI3K, Akt, GSK3, FoxO1), decreased PEPCK activity, and increased HK activity.

Conclusions:

  • Carpachromene demonstrates significant antidiabetic potential by improving glucose metabolism and insulin signaling in an in vitro model.
  • The compound acts centrally on glucose metabolism and insulin signaling through the IR/IRS1/PI3K/Akt/GSK3/FoxO1 pathway.
  • Carpachromene's ability to modulate key components of insulin signaling and glucose metabolism warrants further investigation for therapeutic applications.

Related Concept Videos

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.7K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
14.2K
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
280
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.9K